Stéphane H. Bogen

Affiliations: 
1997-1998 Indiana University, Bloomington, Bloomington, IN, United States 
Google:
"Stéphane Bogen"
Mean distance: 7.74
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bogen S, Gulea M, Fensterbank L, et al. (2019) 5-Endo-Trig Radical Cyclizations of Bromomethyldimethylsilyl Diisopropylpropargylic Ethers. A Highly Diastereoselective Access to Functionalized Cyclopentanes. The Journal of Organic Chemistry. 64: 4920-4925
Bogen S, Fensterbank L, Malacria M. (2019) Study of a Radical Cyclizations Cascade Leading to Bicyclo[3.1.1]heptanes. The Journal of Organic Chemistry. 64: 819-825
Girijavallabhan V, Arasappan A, Bennett F, et al. (2016) 2'-Modified Guanosine Analogs for the Treatment of HCV. Nucleosides, Nucleotides & Nucleic Acids. 1-18
Dang Q, Zhang Z, Bai Y, et al. (2014) Syntheses of nucleosides with a 1′,2′-β-lactam moiety as potential inhibitors of hepatitis C virus NS5B polymerase Tetrahedron Letters. 55: 5576-5579
Dang Q, Zhang Z, Chen T, et al. (2014) Syntheses of 1′,2′-cyclopentyl nucleosides as potential antiviral agents Tetrahedron Letters. 55: 5092-5095
Dang Q, Zhang Z, He S, et al. (2014) Syntheses of 4′-spirocyclic phosphono-nucleosides as potential inhibitors of hepatitis C virus NS5B polymerase Tetrahedron Letters. 55: 4407-4409
Dang Q, Zhang Z, Tang B, et al. (2014) Syntheses of nucleosides with 2′-spirolactam and 2′- spiropyrrolidine moieties as potential inhibitors of hepatitis C virus NS5B polymerase Tetrahedron Letters. 55: 3813-3816
Wang Y, Lipari P, Mirza A, et al. (2012) Abstract 2785: Discovery of a novel HDM2 inhibitor with potent in vivo anti-tumor activity Cancer Research. 72: 2785-2785
Velázquez F, Sannigrahi M, Bennett F, et al. (2010) Cyclic sulfones as novel P3-caps for hepatitis C virus NS3/4A (HCV NS3/4A) protease inhibitors: synthesis and evaluation of inhibitors with improved potency and pharmacokinetic profiles. Journal of Medicinal Chemistry. 53: 3075-85
Nair LG, Bogen S, Ruan S, et al. (2010) Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 1689-92
See more...